By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
Despite management's optimism, Hain Celestial's turnaround remains fragile with a 6% organic sales decline, razor-thin margins, and high leverage. The company is trapped in a 'death spiral' of pricing, ceding shelf space to private labels and struggling to drive genuine growth.
Risk: Structural trap of pricing, leading to a 'death spiral' and loss of shelf velocity required for future recovery.
Opportunity: Successful execution of the innovation pipeline to deliver immediate, high-margin revenue.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Image source: The Motley Fool.
Monday, May 11, 2026 at 8:00 a.m. ET
- Chief Executive Officer — Alison Lewis
- Chief Financial Officer — Lee Boyce
Alison Lewis: Thank you, Alexis. Good morning, everyone, and thank you all for joining the call. Our third quarter performance reflects improved execution and financial discipline as we continue to strengthen our foundation and advance our turnaround strategy. We remain focused on our near-term priorities, optimizing cash strengthening the balance sheet, improving profitability and stabilizing sales. As a reminder, our goal is to position Hain for sustainable growth. The road map to achieving that growth is guided by our 5 actions to win: Portfolio streamlining, accelerating brand renovation and innovation; revenue growth management and pricing; productivity and working capital management; and enhanced digital capabilities.
During the quarter, strong cash generation and total debt reduction of $155 million materially improved our financial position with a major contribution coming from the completion of the North America Snacks business divestiture. From an operating perspective, we delivered Q3 adjusted EBITDA of $26 million, reflecting disciplined execution. Overall profitability improved sequentially with both gross margin and adjusted EBITDA margin improving versus Q2. While our organic net sales performance was not as strong as we expected, the resilience we are seeing across much of the portfolio based on the actions we have put in place is encouraging, and we understand and are actively addressing several isolated challenges.
Importantly, the work we have accelerated in innovation as a clear differentiator in our turnaround. We have significantly stronger renovation and innovation pipelines, meaningful new news to reenergize core categories. Recent launches delivering early share gains and a clear focus on continuing to scale these wins to drive sustainable growth. I'll now drill down into the net sales drivers, including the progress on innovation as we review each of our regions. Q3 was a pivotal quarter for North America. We completed the divestiture of the Snacks business and made good progress in eliminating associated stranded costs, which Lee will expand on.
The remaining core North American business is more focused, stable and profitable portfolio capable of generating gross margins exceeding 30% and low double-digit adjusted EBITDA margin. In the third quarter, North America organic net sales declined 3%, which was consistent with Q2 trends, excluding the impact of that divestiture. Importantly, our core business is stable with organic net sales growth across yogurt, tea, baby & kids: finger foods and cereal. And we delivered expansion in both gross margin and adjusted EBITDA margin year-over-year. Sales pressure in the quarter was largely confined to select smaller brands and included the impact of portfolio simplification as we will discuss. Notably, we continue to see improving innovation, driving momentum and share gains.
Let me give you more color on how our innovation success is contributing to core category performance. In tea, wellness tea remains a bright spot with dollar sales up high single digits and segment share gains in the quarter, supported by strong distribution increases and elevated consumer demand in functional benefit areas. Building upon this momentum, Celestial Seasonings is expanding its wellness platform with innovation launching beginning this month in gut health and throat support, further broadening its presence in these high-growth segments. This builds upon the successful wellness launches this year in emerging benefit areas: Detox, energy and women's wellness.
In baby & kids, finger foods remains the primary growth driver with Earth's Best holding the #2 position in this segment. Momentum continues behind our self-feeding platform, particularly our crunchy sticks Teething snacks. We are energized about the upcoming launch of Earth's Best Big Kids finger food. This multi-SKU expansion with protein and fiber for high-density nutrition is designed to extend the brand into new consumption occasions beyond baby and toddler into its backpack territory, and will be supported by a full funnel marketing campaign. In yogurt, Greek Gods continues to exhibit strong momentum with high-teen dollar sales growth and share gain.
Multi-serve remains the foundation of the business continuing to drive performance, and we have the power to expand distribution supported by strong underlying demand. Innovation remains a key focus, and we are moving with pace against the biggest growth opportunities. Our new single-serve packaging format is beginning to scale, helping to drive trial and introduce new customers to the brand. We are seeing promising incrementality both to the Greek Gods brand and to the single-serve category as a whole. In April, at select grocery retailers, Greek Gods launched a new high-protein offering, delivering 20 grams of protein per serving while maintaining the brand's differentiated indulgent taste profile.
As we move through the balance of fiscal 2026, we remain focused on advancing our turnaround strategy and positioning Hain for sustainable growth at or above category growth rates. Across our portfolio, key performance indicators point to improving brand health and stronger execution. We are increasingly effective at reaching and engaging core consumers through a more disciplined digitally-led approach with measurable returns and the momentum is evident across our core. Supported by an accelerated innovation and renovation pipeline, we are executing with greater consistency and impact, reinforcing our path towards a more focused, resilient and built-to-win Hain in North America. Turning now to our international business.
We have a portfolio of well-recognized and loved brands with decades of quality and category leadership and a track record of resilient financial performance. The categories we operate in have struggled with volume as heightened geopolitical uncertainty and elevated inflation, including rising fuel prices are contributing to a decline in U.K. and European consumer confidence. In the quarter, we saw an organic net sales decline of 8% due to continued industry-wide volume softness in wet baby food ongoing challenges in spreads and drizzles as well as a decline in branded soup from a challenging year-ago comparison and strong private label competition. As a result, gross margin and adjusted EBITDA margin contracted in the quarter.
The industry-wide decline we have seen in purees in the Baby and Kids category has stabilized, and we expect it to begin to recover as this month, we anniversary the beginning of the slowdown. As a reminder, the industry decline began last May, following a [BBC] documentary on nutritional content in baby food. Encouragingly, we have seen early signs of consumption improvement in Ella's Kitchen in the last two months. Ella's Kitchen remains the #1 baby and kids food brand in the U.K. and Ireland. We have a strong pipeline of finger foods and new frozen meals innovation coming to the market, all supported by exceptionally strong nutritional credentials when compared to the competitive set.
All of our innovation will be completely in-line with Office for Health Improvement and Disparities guidelines. The launches are backed by fully integrated end-to-end marketing activation. We believe this innovation will fuel the category and brand recovery by bringing new news at shelf while advancing our better for little ones positioning. The spreads and drizzles category continues to be challenged as increased consumer focus on health and wellness is impacting consumption patterns. We are leaning in and making bold moves with a robust end-to-end transformation of the Hartley's brand, anchored by a full relaunch hitting shelves in June.
This includes comprehensive product reformulation across the core portfolio with meaningful upgrades to improve fruit content and flavor and a step change in better-for-you innovation. As part of this relaunch, we are also rolling out Hartley's first ever 100% fruit spread along with new fruit flavor combination products designed to energize the category. The brand will debut with a new visual look and feel and will be supported by premium pricing and an in-store promotion strategy for consumption acceleration. Along with consumer communication designed to drive trial, reappraisal and category engagement. This innovation has been very well received by retail partners with expanded distribution and support confirmed for Q1.
Additionally, we continue to address near-term margin pressures by optimizing our manufacturing operations. In soup, we are the market leader with the top three brands in the U.K. New Covent Garden, Yorkshire Provender, and Cully & Sully, which span distinct propositions and good, better, best price tiers. Our most premium offering, Cully & Sully, again grew value double digits and share. And our private label soup grew organic net sales by high single digits. However, our remaining brands face aggressive private label competition and a tough distribution gain comparison in the year-ago period. We have a full brand relaunch plan for Yorkshire Provender this fall, representing a meaningful upgrade to the franchise.
We are updating every single recipe with high-quality ingredients redesigning the packaging to visually demonstrate our naturally abundant and honestly delicious food and introducing premium innovation through our special collection and adding [too] to our successful destination launch program. In spite of the pressure points in Baby & Kids, spreads and drizzles and soup, 50% of our brands are holding or gaining share, demonstrating brand and competitive strength in a tougher operating environment. We see renovation and innovation-led growth critical to energizing the categories with innovation rates that are accelerating across the portfolio.
Our innovation renewal rate or percent of net sales coming from SKUs launched or relaunched the last 3 years was more than 12% in the quarter, up over 2.5 points from a year ago. And we have significant renovation and innovation plan for Q4 and beyond as we have discussed. This innovation, along with the lap of the start of the industry-wide baby food softness is expected to drive improved organic net sales trends in Q4. Before I turn the call over to Lee for a closer look at the financials, I want to touch briefly on our ongoing strategic review. We are in the execution phase and our first action against North America snacks has been completed.
We are actively executing additional actions with a clear priority on further deleveraging and driving long-term shareholder value. As we've indicated previously, while this work is ongoing, we will provide updates only when there are definitive actions or outcomes to share. With that, I'll turn the call over to Lee for a more detailed discussion of Q3 results.
Lee Boyce: Thank you, Alison, and good morning, everyone. Before I go through our Q3 performance, I want to remind everyone that we completed the sale of our North American snacks business on February 27, 2026. Accordingly, our reported and adjusted financial results contain the results of North American snacks in January and February, but not in March. When we speak about organic net sales, by definition, we exclude the results of North American snacks from the calculation, both in the current quarter as well as in the comparable period. When we talk about certain items, excluding snacks, we exclude the impact of North American snacks and TSA proceeds and assume removal of associated stranded costs.
For the third quarter, we saw an organic net sales decline of 6% year-over-year, driven primarily by lower sales in the International segment. The decline in organic net sales reflects an 11-point decrease in volume mix and a 5-point increase in price. Adjusted gross margin was 21% in the third quarter. This represents an approximately 90 basis point decrease year-over-year, while improving by approximately 150 basis points sequentially. The year-over-year decrease was driven primarily by inflation and lower volume mix, partially offset by productivity savings and pricing. The sequential increase reflects the North American snacks divestiture as well as actions taken, including SKU simplification, more effective trade management, targeted pricing and productivity initiatives.
SG&A decreased 6% year-over-year to $59 million in the third quarter, primarily driven by a reduction in employee-related expenses. SG&A represented 17.5% of net sales for the quarter as compared to 16.1% in the year ago period. SG&A stranded costs less the impact of mitigation actions and TSA proceeds were negligible in the quarter. As Alison mentioned, we are making good progress in the elimination of stranded costs, which are now expected to be in the high end of the $20 million to $25 million range. We've already initiated actions to remove nearly 70%, primarily people-related costs, which we were able to implement quickly.
The remaining costs will be reduced through fiscal 2027, with roughly half coming out by the end of Q2 and the remainder by the end of Q4. In the near term, our transition services agreement, or TSA, is generating proceeds from providing ongoing support to the recently divested snacks business. Together with actions taken to date, this has essentially eliminated any near-term stranded cost impact. We are nearly finished with our restructuring program to date, having taken $108 million in charges associated with the transformation program, excluding inventory write-downs, out of an expected charges of $115 million to $125 million. We remain on track to deliver the targeted $130 million to $150 million in benefits through fiscal 2027.
Interest expense rose 17% year-over-year to $14 million in the quarter, primarily driven by higher spreads over variable rates due to last year's refinancing as well as increased amortization of deferred financing fees related to the credit agreement amendment and repayment of term loans using proceeds from the snacks divestiture. We have hedged our rate exposure of more than 70% of our loan facility with fixed rate of 7.1%. We continue to prioritize reducing net debt over time.
Adjusted net loss, which excludes the effect of restructuring charges amongst other items, was $1 million in the quarter, or $0.01 per diluted share as compared to adjusted net income of $6 million or $0.07 per diluted share in the prior year period. We delivered adjusted EBITDA of $26 million in the third quarter compared to $34 million a year ago. The decrease was driven primarily by lower gross margins partially offset by a reduction in SG&A. Adjusted EBITDA margin was 7.8%, demonstrating sequen
Four leading AI models discuss this article
"Hain Celestial's reliance on aggressive cost-cutting and divestitures to mask persistent volume declines suggests a structural inability to compete in its core categories."
Hain Celestial is in a classic 'value trap' scenario. While management touts 'financial discipline' and portfolio streamlining, the underlying organic net sales decline of 6% is alarming, especially with an 11-point volume/mix headwind. They are essentially shrinking to greatness, but the divestiture of the snacks business—while necessary for deleveraging—removes a potential growth engine. The 7.8% adjusted EBITDA margin is razor-thin for a CPG company, leaving almost no buffer for execution errors or further inflationary shocks. Unless the 'innovation pipeline' delivers immediate, high-margin revenue, the company remains trapped in a cycle of cost-cutting to offset volume erosion rather than driving genuine growth.
If the divestiture of the snacks business successfully clears the balance sheet and the 'innovation-led' recovery in the UK and North America gains traction, HAIN could be an undervalued turnaround play trading at a significant discount to its historical multiples.
"Persistent YoY sales and EBITDA declines despite divestiture mask weak core demand, risking further erosion if innovation fails to deliver in a volume-challenged CPG sector."
HAIN's Q3 organic sales declined 6% YoY (-3% North America ex-snacks, -8% International), with volume/mix down 11 points partially offset by 5-point pricing; adjusted EBITDA fell to $26M (7.8% margin) from $34M YoY, though up sequentially on divestiture and cost cuts. Snacks sale slashed debt $155M (70%+ hedged at 7.1%), stranded costs now high-$20M-$25M range mostly mitigated. Innovation (12% renewal rate, up 2.5 pts) shows pockets like Greek Gods high-teens growth, but macro headwinds (UK baby food post-BBC, inflation) and historical execution slips temper outlook—Q4 'improvement' lacks quantified guidance.
Debt deleveraging and sequential margin expansion (gross margin +150bps QoQ to 21%) via productivity/SKU simplification build a leaner base for innovation-driven inflection, especially as baby food lapping slowdown and launches like Hartley's relaunch gain retail support.
"HAIN has arrested margin deterioration and reduced debt, but is masking accelerating volume loss through pricing that will reverse if macroeconomic conditions worsen, leaving leverage unmanageable."
HAIN is executing a credible operational turnaround—$155M debt reduction, improving sequential margins (150bps), innovation driving share gains in core categories (Greek Gods +high teens, wellness tea +high single digits). But the headline 6% organic sales decline masks a brutal 11-point volume/mix headwind offset only by 5-point pricing. International is collapsing (8% decline) with baby food still in recovery mode post-BBC scandal. The company is burning through restructuring charges ($108M of $115-125M) while stranded costs linger into Q4 2027. Most concerning: they're pricing into weakness during consumer confidence collapse in U.K./Europe, and the innovation pipeline's early wins haven't yet arrested the core volume problem.
The strongest case against this is that pricing 5 points into an 11-point volume decline signals demand destruction, not stabilization—and if consumer confidence keeps deteriorating through 2026-2027, that pricing sticks and volumes crater further, making the debt math unsustainable.
"The turnaround remains unproven; without durable revenue growth from the innovation pipeline and timely cost reductions, the stock faces downside risk despite the snacks divestiture."
Hain Celestial’s Q3 narrative leans toward a turn toward profitability after selling North American Snacks, but the numbers don’t fully back a safe rebound. Organic net sales fell 6% YoY (excluding snacks), adjusted gross margin sits at 21%, and adjusted EBITDA margin around 7.8%—clear evidence the turnaround is still fragile. The international weakness persists, and even with a purported core North America margin >30% gross and a low double-digit EBITDA, the company’s overall leverage remains high and interest costs rose 17% to $14m. Management’s optimism hinges on a robust innovation pipeline delivering durable growth; execution risk and cost-out timing remain substantial headwinds in a inflationary, private-label-heavy environment.
The strongest counter is that the ‘improving margins’ claim hinges on the North America core while international weakness lingers; if those savings don’t materialize on schedule and if consumer demand falters, leverage stays elevated and the stock multiple could compress.
"The company's pricing strategy is actively accelerating brand erosion by forcing consumers toward cheaper private-label alternatives."
Claude, you’re right to highlight the demand destruction, but you’re missing the structural trap: HAIN is trapped in a 'death spiral' of pricing. By pushing 5% pricing into an 11-point volume decline, they are effectively ceding shelf space to private labels, which are currently gaining massive share in the wellness segment. This isn't just a 'turnaround'—it’s a brand equity liquidation. Without a pricing pivot, they will lose the very shelf velocity required to sustain any future innovation-led recovery.
"Premium innovation is driving share gains despite pricing, challenging the private label ceding narrative."
Gemini, your private label 'death spiral' ignores HAIN's share gains in premium pockets—Greek Gods high-teens growth, wellness tea high-single digits—directly countering volume erosion. Pricing defends gross margins (up 150bps QoQ) during reset, not liquidation. Unmentioned risk: if stranded costs ($20-25M) drag past 2025 mitigation as Claude flags, FCF stays pinned, delaying re-rating.
"Premium product outperformance during core volume collapse signals portfolio liquidation, not turnaround stabilization."
Grok's Greek Gods high-teens growth doesn't disprove Gemini's death spiral—it proves it. Premium pockets thriving while core volume collapses 11 points means HAIN is cannibalizing its own portfolio, not defending it. The 150bps gross margin gain is accounting sleight: mix-shift to higher-margin premium products masks that core categories are losing shelf velocity to private label. If stranded costs persist and innovation can't arrest the 8% international decline, that premium growth becomes a shrinking island.
"The bear case hinges on whether the 150bps gross-margin uplift and cost-out are durable enough to offset ongoing international weakness and stranded costs; without that, the 'premium pockets' may not support a sustainable re-rating."
Gemini's 'death spiral' framing hinges on price-in elasticity; Grok's premium pockets challenge that, but the real risk is durability of the 150bps gross margin lift and the stranded-cost tail. If cost inflation resumes or stranded costs leak into 2026, EBITDA could falter even with premium SKUs. Also, international weakness and private-label share gains could erase any pricing cushion—watch whether Q4/Q1 guidance actually materializes.
Despite management's optimism, Hain Celestial's turnaround remains fragile with a 6% organic sales decline, razor-thin margins, and high leverage. The company is trapped in a 'death spiral' of pricing, ceding shelf space to private labels and struggling to drive genuine growth.
Successful execution of the innovation pipeline to deliver immediate, high-margin revenue.
Structural trap of pricing, leading to a 'death spiral' and loss of shelf velocity required for future recovery.